SCHEMBL4904216

SCHEMBL4904216

CCN(c1ccc(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.53
POLB P06746 1/20 0.51
HDAC3 O15379 3/20 0.48
HDAC11 Q96DB2 3/20 0.48
HDAC8 Q9BY41 3/20 0.48
HDAC6 Q9UBN7 3/20 0.48
LMNA P02545 2/20 0.48
ALDH1A1 P00352 5/20 0.47
MAPT P10636 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
UQCRB P14927 1/20 0.47
HCRTR2 O43614 1/20 0.46
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
CA1 P00915 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904061 0.91 SERPINE1 (0.50) POLBHDAC3HDAC11HDAC8HDAC6
SCHEMBL4906833 0.90 HDAC3 (0.47) PTPN5POLBHDAC3HDAC11HDAC8
SCHEMBL4903148 0.88 LMNA (0.55) POLBLMNAALDH1A1MAPTMEN1
SCHEMBL4908493 0.88 LMNA (0.54) POLBHDAC3HDAC11HDAC8HDAC6
SCHEMBL4895884 0.82 HDAC8 (0.48) POLBHDAC3HDAC11HDAC8HDAC6
SCHEMBL5378765 0.81 POLB (0.65) PTPN5POLBHDAC3HDAC11HDAC8
SCHEMBL4905443 0.79 HDAC8 (0.56) HDAC3HDAC11HDAC8HDAC6LMNA
SCHEMBL4900672 0.79 HDAC8 (0.51) POLBHDAC3HDAC11HDAC8HDAC6
SCHEMBL4903714 0.79 LMNA (0.56) POLBHDAC3HDAC11HDAC8HDAC6
SCHEMBL4905415 0.78 ALDH1A1 (0.50) POLBLMNAALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD PTPN5 2304/4885POLB 1807/4885HDAC3 157/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD PTPN5 2304/4885POLB 1807/4885HDAC3 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.